trending Market Intelligence /marketintelligence/en/news-insights/trending/XsXwD1g71DALuSiUT_N5Tg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Report: Vivo Capital looks to exit Surgical Specialties

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Report: Vivo Capital looks to exit Surgical Specialties

Vivo Capital LLC is weighing a sale for Surgical Specialties Corp. and hired an adviser to gauge buyer interest, Bloomberg News reported, citing people with knowledge of the matter.

The medical-device maker could be worth more than $500 million.

Vivo Capital and ZQ Capital Ltd. co-led an investor group to acquire the Canadian company, then known as Angiotech Pharmaceuticals Inc., in 2017, Bloomberg said.

Representatives for Vivo Capital and Surgical Specialties did not immediately answer requests for comment, according to Bloomberg.